OJOG  Vol.3 No.6 , August 2013
Effect of iron supplementation on glucose transporter 4 expression in adipose tissue and skeletal muscle of pregnant rats
ABSTRACT

Objective: The main goal of the present study was to investigate the effect of iron supplementation on glucose transporter 4 expressions in adipose tissue and skeletal muscle in female rats during pregnancy. Methods: Twenty-four pregnant Sprague-Dawley rats were randomly divided into 2 groups: a control group with a standard diet (containing iron 150 mg/kg) and an iron-supplementation group with a high-iron diet (containing iron 700 mg/kg) from day 0 to day 21 of pregnancy. Intraperitoneal glucose tolerance test was performed on gestational day 19. On gestational day 21, all of the pregnant rats from each group were sacrificed. The mean neonatal weights were measured and samples of maternal intraabdominal adipose tissue and skeletal muscle were taken to measure the expression of Glucose Transporter 4 (GLUT4) mRNA and protein. Results: Glucose tolerance decreased significantly in the iron supplementation group compared to the control group. The mean neonatal weights in the iron supplementation group were higher than that in the control group. Levels of GLUT4 mRNA in the adipose tissue were reduced by the administrations of high-iron diet. The skeletal muscle GLUT4 mRNA levels were not changed significantly by iron supplementation. Expression of GLUT4 protein both in the adipose tissue and skeletal muscle reduced significantly. Conclusion: These results suggest that iron supplementation during pregnancy would increase neonatal weights and could decrease maternal glucose tolerance by interfering GLUT4 expression in adipose tissue and skeletal muscle of rats.


Cite this paper
He, M. , Jiang, J. , Liu, S. and Cheng, H. (2013) Effect of iron supplementation on glucose transporter 4 expression in adipose tissue and skeletal muscle of pregnant rats. Open Journal of Obstetrics and Gynecology, 3, 500-507. doi: 10.4236/ojog.2013.36091.
References
[1]   Bothwell, T.H. (2000) Iron requirements in pregnancy and strategies to meet them. American Journal of Clinical Nutrition, 72, 257S-263S.

[2]   Habib, F., Alabdin, E.H.Z., Alenazy, M. and Nooh, R. (2009) Compliance to iron supplementation during pregnancy. Journal of Obstetrics and Gynaecology, 29, 487-492. doi:10.1080/01443610902984961

[3]   Cogswell, M.E., Parvanta, I., Ickes, L., Yip, R. and Brittenham, G.M. (2003) Iron supplementation during pregnancy, anemia, and birth weight: A randomized controlled trial. American Journal of Clinical Nutrition, 78, 773-781.

[4]   Rioux, F.M., Lindmark, G. and Hernell, O. (2006) Does inadequate maternal iron or DHA status have a negative impact on an infant’s functional outcomes? Acta Paediatrica, 95, 137-144. doi:10.1080/08035250500281814

[5]   Rajpathak, S.N., Crandall, J.P., Wylie-Rosett, J., Kabat, G.C., Rohan, T.E. and Hu, F.B. (2009) The role of iron in type 2 diabetes in humans. Biochimica et Biophysica Acta (BBA)-General Subjects, 1790, 671-681. doi:10.1016/j.bbagen.2008.04.005

[6]   Luan, D.C., Li, H., Li, S.J., Zhao, Z., Li, X. and Liu, Z.M. (2008) Body iron stores and dietary iron intake in relation to diabetes in adults in north China. Diabetes Care, 31, 285-286. doi:10.2337/dc07-0921

[7]   Jiang, R., Manson, J.E., Meigs, J.B., Ma, J., Rifai, N. and Hu, F.B. (2004) Body iron stores in relation to risk of type 2 diabetes in apparently healthy women. Jama-Journal of the American Medical Association, 291, 711-717. doi:10.1001/jama.291.6.711

[8]   Lao, T.T., Tam, K.F. and Chan, L.Y. (2000) Third trimester iron status and pregnancy outcome in non-anaemic women; pregnancy unfavourably affected by maternal iron excess. Human Reproduction, 15, 1843-1848. doi:10.1093/humrep/15.8.1843

[9]   Lao, T.T., Chan, L.Y., Tam, K.F. and Ho, L.F. (2002) Maternal hemoglobin and risk of gestational diabetes mellitus in Chinese women. Obstetrics and Gynecology, 99, 807-812. doi:10.1016/S0029-7844(02)01941-5

[10]   Lao, T.T. and Ho, L.F. (2004) Impact of iron deficiency anemia on prevalence of gestational diabetes mellitus. Diabetes Care, 27, 650-656. doi:10.2337/diacare.27.3.650

[11]   Charron, M.J., Katz, E.B. and Olson, A.L. (1999) GLUT4 gene regulation and manipulation. Journal of Biological Chemistry, 274, 3253-3256. doi:10.1074/jbc.274.6.3253

[12]   Yamada, K., Yamakawa, K., Terada, Y., Kawaguchi, K., Sugaya, A., Sugiyama, T. and Toyoda, N. (1999) Expression of GLUT4 glucose transporter protein in adipose tissue and skeletal muscle from streptozotocin-induced diabetic pregnant rats. Hormone and Metabolic Research, 31, 508-513.

[13]   Okuno, S., Akazawa, S., Yasuhi, I., Kawasaki, E., Matsumoto, K., Yamasaki, H., Matsuo, H., Yamaguchi, Y. and Nagataki, S. (1995) Decreased expression of the glut4 glucose-transporter protein in adipose-tissue during pregnancy. Hormone and Metabolic Research, 27, 231-234. doi:10.1055/s-2007-979946

[14]   Smirnakis, K.V., Martinez, A., Blatman, K.H., Wolf, M., Ecker, J.L. and Thadhani, R. (2005) Early pregnancy insulin resistance and subsequent gestational diabetes mellitus. Diabetes Care, 28, 1207-1208. doi:10.2337/diacare.28.5.1207

[15]   Colomiere, M., Permezel, M. and Lappas, M. (2010) Diabetes and obesity during pregnancy alter insulin signalling and glucose transporter expression in maternal skeletal muscle and subcutaneous adipose tissue. Journal of Molecular Endocrinology, 44, 213-223. doi:10.1677/JME-09-0091

[16]   Stanley, K., Fraser, R. and Bruce, C. (1998) Physiological changes in insulin resistance in human pregnancy: Longitudinal study with the hyperinsulinaemic euglycaemic clamp technique. British Journal of Obstetrics and Gynaecology, 105, 756-759. doi:10.1111/j.1471-0528.1998.tb10207.x

[17]   Martinez-Garcia, M.A., Luque-Ramirez, M., San-Millan, J.L. and Escobar-Morreale, H.F. (2009) Body iron stores and glucose intolerance in premenopausal women role of hyperandrogenism, insulin resistance, and genomic variants related to inflammation, oxidative stress, and iron metabolism. Diabetes Care, 32, 1525-1530. doi:10.2337/dc09-0420

[18]   Le Guenno, G., Chansaume, E., Ruivard, M., Morio, B. and Mazur, A. (2007) Study of iron metabolism disturbances in an animal model of insulin resistance. Diabetes Research and Clinical Practice, 77, 363-370. doi:10.1016/j.diabres.2007.02.004

[19]   Menendez, C., Todd, J., Alonso, P.L., Francis, N., Lulat, S., Ceesay, S., Mboge, B. and Greenwood, B.M. (1994) The effects of iron supplementation during pregnancy, given by traditional birth attendants, on the prevalence of anemia and malaria. Transactions of the Royal Society of Tropical Medicine and Hygiene, 88, 590-593. doi:10.1016/0035-9203(94)90176-7

[20]   Ward, R.J., Wilmet, S., Legssyer, R., Leroy, D., Toussaint, L., Crichton, R.R., Pierreux, C., Hue, L., Piette, J., Srai, S.K., Solanky, N., Klein, D. and Summer, K. (2009) Effects of marginal iron overload on iron homeostasis and immune function in alveolar macrophages isolated from pregnant and normal rats. Biometals, 22, 211-223. doi:10.1007/s10534-008-9155-6

[21]   Thomas, M.C., MacIsaac, R.J., Tsalamandris, C. and Jerums, G. (2004) Elevated iron indices in patients with diabetes. Diabetic Medicine, 21, 798-802. doi:10.1111/j.1464-5491.2004.01196.x

[22]   Bo, S., Menato, G., Villois, P., Gambino, R., Cassader, M., Cotrino, I. and Cavallo-Perin, P. (2009) Iron supplementation and gestational diabetes in midpregnancy. American Journal of Obstetrics and Gynecology, 201, 6. doi:10.1016/j.ajog.2009.04.049

[23]   Afkhami-Ardekani, M. and Rashidi, M. (2009) Iron status in women with and without gestational diabetes mellitus. Journal of Diabetes and Its Complications, 23, 194-198. doi:10.1016/j.jdiacomp.2007.11.006

[24]   Hultcrantz, R. (2006) Iron overload and the metabolic syndrome. Scandinavian Journal of Gastroenterology, 41, 756-759.

[25]   Wrede, C.E., Buettner, R., Bollheimer, L.C., Scholmerich, J., Palitzsch, K.D. and Hellerbrand, C. (2006) Association between serum ferritin and the insulin resistance syndrome in a representative population. European Journal of Endocrinology, 154, 333-340. doi:10.1530/eje.1.02083

[26]   Dongiovanni, P., Valenti, L., Fracanzani, A.L., Gatti, S., Cairo, G. and Fargion, S. (2008) Iron depletion by deferoxamine up-regulates glucose uptake and insulin signaling in hepatoma cells and in rat liver. American Journal of Pathology, 172, 738-747. doi:10.2353/ajpath.2008.070097

[27]   Ozyigit, E.A., Ugur, M., Unlu, S., Ozaksit, G. and Avsar, F. (2008) The effect of oral iron supplementation on the glucose metabolism in non-anemic pregnant women: A prospective case-control study. Uhod-Uluslararasi Hematoloji-OnkolojiDergisi, 18, 155-162.

[28]   Chibalin, A.V., Leng, Y., Vieira, E., Krook, A., Bjoernholm, M., Long, Y.C., Kotova, O., Zhong, Z.H., Sakane, F., Steiler, T., Nylen, C., Wang, J.J., Laakso, M., Topham, M.K., Gilbert, M., Wallberg-Henriksson, H. and Zierath, J.R. (2008) Downregulation of diacylglycerol kinase delta contributes to hyperglycemia-induced insulin resistance. Cell1, 32, 375-386. doi:10.1016/j.cell.2007.12.035

[29]   Holland, W.L., Brozinick, J.T., Wang, L.P., Hawkins, E.D., Sargent, K.M., Liu, Y.Q., Narra, K., Hoehn, K.L., Knotts, T.A., Siesky, A., Nelson, D.H., Karathanasis, S.K., Fontenot, G.K., Birnbaum, M.J. and Summers, S.A. (2007) Inhibition of ceramide synthesis ameliorates glucocorticoid-, saturated-fat-, and obesity-induced insulin resistance. Cell Metabolism, 5, 167-179. doi:10.1016/j.cmet.2007.01.002

[30]   Griesel, B.A., Weems, J., Russell, R.A., Abel, E.D., Humphries, K. and Olson, A.L. (2010) Acute inhibition of fatty acid import inhibits GLUT4 transcription in adipose tissue, but not skeletal or cardiac muscle tissue, partly through liver X receptor (LXR) signaling. Diabetes, 59, 800-807. doi:10.2337/db09-1542

[31]   Sugaya, A., Sugiyama, T., Yanase, S., Shen, X.X., Minoura, H. and Toyoda, N. (2000) Expression of glucose transporter 4 mRNA in adipose tissue and skeletal muscle of ovariectomized rats treated with sex steroid hormones. Life Sciences, 66, 641-648. doi:10.1016/S0024-3205(99)00636-0

[32]   Stenbit, A.E., Tsao, T.S., Li, J., Burcelin, R., Geenen, D.L., Factor, S.M., Houseknecht, K., Katz, E.B. and Charron, M.J. (1997) GLUT4 heterozygous knockout mice develop muscle insulin resistance and diabetes. Nature Medicine, 3, 1096-1101. doi:10.1038/nm1097-1096

[33]   Poletto, A.C., Anhe, G.F., Eichler, P., Takahashi, H.K., Furuya, D.T., Okamoto, M.M., Curi, R. and Machado, U.F. (2010) Soybean and sunflower oil-induced insulin resistance correlates with impaired GLUT4 protein expression and translocation specifically in white adipose tissue. Cell Biochemistry and Function, 28, 114-121. doi:10.1002/cbf.1628

[34]   Rincon, J., Holmang, A., Wahlstrom, E.O., Lonnroth, P., Bjorntorp, P., Zierath, J.R. and WallbergHenriksson, H. (1996) Mechanisms behind insulin resistance in rat skeletal muscle after oophorectomy and additional testosrone treatment. Diabetes, 45, 615-621. doi:10.2337/dia betes.45.5.615

[35]   Cooksey, R.C., Jouihan, H.A., Ajioka, R.S., Hazel, M.W., Jones, D.L., Kushner, J.P. and McClain, D.A. (2004) Oxidative stress, beta-cell apoptosis, and decreased insulin secretory capacity in mouse models of hemochromatosis. Endocrinology, 145, 5305-5312. doi:10.1210/en.2004-0392

[36]   Mendler, M.H., Turlin, B., Moirand, R., Jouanolle, A.M., Sapey, T., Guyader, D., Le Gall, J.Y., Brissot, P., David, V. and Deugnier, Y. (1999) Insulin resistance-associated hepatic iron overload. Gastroenterology, 117, 1155-1163. doi:10.1016/S0016-5085(99)70401-4

[37]   Huang, J.Y., Jones, D., Luo, B., Sanderson, M., Soto, J., Abel, E.D., Cooksey, R.C. and McClain, D.A. (2011) Iron overload and diabetes risk: A shift from glucose to fatty acid oxidation and increased hepatic glucose production in a mouse model of hereditary hemochromatosis. Diabetes, 60, 80-87. doi:10.2337/db10-0593

[38]   McCarty, M.F. (2003) Hyperinsulinemia may boost both hematocrit and iron absorption by up-regulating activity of hypoxia-inducible factor-1 alpha. Medical Hypotheses, 61, 567-573. doi:10.1016/S0306-9877(03)00231-7

[39]   Pena-Rosas, J.P. and Viteri, F.E. (2009) Effects and safety of preventive oral iron or iron plus folic acid supplemenion for women during pregnancy. Cochrane Database of Systematic Reviews, 234, Article No. D004736.

 
 
Top